Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval
Crossref DOI link: https://doi.org/10.1007/s40258-016-0291-9
Published Online: 2016-11-10
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chambers, James D.
Thorat, Teja
Wilkinson, Colby L.
Salem, Mark
Subedi, Prasun
Kamal-Bahl, Sachin J.
Neumann, Peter J.
License valid from 2016-11-10